Mizkan Holdings Co., Ltd.   Report issue

For profit
Founded: Handa Japan (1804)
Status: No NME R&D (1804)

Organization Overview

First Clinical Trial
2018
NCT03596099
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Mizkan Holdings Co., Ltd.

Active Ingredients

Drugs in Other Trials (2)

acetic acid (vosol) (1 trial)

oryza sativa (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2